{"nct_id":"NCT02000440","title":"A Phase II, Repeat Dose, Proof of Mechanism Study of Losmapimod to Reduce Proteinuria in Patients With Focal Segmental Glomerulosclerosis (FSGS)","status":"COMPLETED","status_verified_date":"2017-03","start_date":"2014-07-01","start_date_type":null,"primary_completion_date":"2016-02-29","primary_completion_date_type":"ACTUAL","completion_date":"2016-05-11","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GSK"]}